Table 1 The diagnosis of patients included in to the retrospective database
From: Developing a research database of primary aldosteronism: rationale and baseline characteristics
| Â | n/N (%) |
|---|---|
Patients diagnosed as PA | 862 (100%) |
 Positive ARR | 583/862 (67.6%) |
 Screening not stated | 279/862 (32.4%) |
Patients with confirmation test | 507/862 (55.82%) |
 Positive SIT | 443/507 (87.4%) |
 Positive CCT | 408/507 (80.5%) |
 Positive both test | 344/507 (67.9%) |
Patients with alternative confirmation test | 355/862 (41.2%) |
 ARR > 20 | 76/355 (21.4%) |
 Confirmation not stated | 279/355 (78.6%) |
Patients with subtype classification | 479/862 (55.6%) |
 Adrenal vein sampling (AVS) | 190/862 (22.3%) |
  Unilateral disease | 63/190 (33.2%) |
  Bilateral disease | 50/190 (26.3%) |
  Unsatisfactory or indeterminate | 77/190 (40.5%) |
 Imaging (CT/MRI etc.) | 366/862 (%) |
  Unilateral adenoma | 345/366 (94.3%) |
  Bilateral hyperplasia | 21/366 (5.7%) |
Patients with a definitive diagnosis | 480/862 (55.7%) |
 Aldosterone producing adenoma (APA) | 408/862 (47.3%) |
  By AVS + Patho | 63 /408 (15.4%) |
  By imaging + Patho | 345/408 (84.6%) |
 Bilateral aldosterone hyperplasia | 72 /862 (8.4%) |
  By AVS | 50/72 (69.4%) |
  By imaging | 21/72 (29.2%) |
  By patho | 1/72 (1.4%) |